ERBB2 and ductal breast carcinoma in situ: An increased immune presence in DCIS tissue is associated with poor prognostic features including high grade, hormone receptor negativity, HER2 positivity and comedo necrosis, suggesting that more aggressive tumors trigger a more intense immune response than less aggressive tumors (Table 6) [84, 85, 104, 113–119].